How To Write Covered Calls - An Ongoing Real Case Study! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : How To Write Covered Calls - An Ongoing Real Case Study!

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Herm who wrote (1693)	4/14/1997 9:24:00 PM
From: Jonathan Thomas	of 14162

Thanks Herm, Call me Ryan..:) DRMD got denied by the FDA a month or 2 ago, and I was amazed at how quickly it rebounded. I really think that it has a stable foundation, and on top of that it could get lucky. The biotechs seem to hold their ground pretty well. I have been waiting, assuming it would slump after that announcement, and with their earning status, but someone sees something in the company. Think what will happen if they get FDA approval, right back up into the 20's. When I finish my repairs on QDEK, I'm going after DRMD or AXC, have been watching both for a while, and I prefer to buy at least 1000-2000 shares, thats how the big CC bucks roll in. I think you are right about the amount of CCing done on DRMD by the way. With that volume, there can't be any other reason why the premies are so high. Ryan

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next